Skip to main content
Cannabis News

International Cannabinoid Research Symposium 2013 Overview

By July 17, 2013August 3rd, 2020No Comments

 International Cannabinoid Research Symposium Trip 2013

Quantum 9,a medical marijuana consulting and grow automation technology firm, attended the International Cannabinoid Research Symposium 2013 (ICSR). The conference in Vancouver, British Columbia was from June 21 – 26, 2013. The event marked the 23rd Annual International Cannabinoid Research Society Symposium on the cannabinoid sciences.

TheInternational Cannabinoid Research Symposium was less successful than previous years due to the lack of funding in the cannabinoid sciences field. This was evident in the sample sizes of laboratory research studies and overall attendance. The event was not cheap, $1,125 per attendee plus $58 an evening stay, for five days, on University of British Columbia Campus. There was an additional charge of $150 for attending the Clinical Day on top of all of the other charges including international fees.

International Cannabinoid Research Symposium

International Cannabinoid Research Symposium

My personal journey started in Chicago to the International Cannabinoid Research Symposium where I sat next to one of the most brilliant up and coming cannabinoid research scientist. On the plane ride, I quickly found out we shared similar passions in the cannabis field. He taught me about science and medical breakthroughs, the medical vernacular. I taught him about the cannabis plant itself. Our conversations were mind blowing, and we became instant friends.

Plane Ride

We spoke about Quantum 9’s cannabis consulting practice. I helped him with this PowerPoint presentation during our five hour flight to the beautiful city of Vancouver. Pritesh went on to win an award for one of the best oral presentations at the conference. I’m not going to be as bold as saying I had much to do with Pritesh’s win. I will say that my help didn’t hurt. Unfortunately, during his cutting edge, groundbreaking, award winning presentation I was not in attendance due to back issues. I recently had a lumbar laminectomy to address a L4/L5 and L5/S1 herniated discs.

Chat with Pritesh before the International Cannabinoid Research Symposium

The worst part is that Pritesh gave Quantum 9 a shout out during his presentation. I wasn’t there to witness it. Pritesh ‘s research focuses on the integration of computer modeling and pharmacological testing of compounds to identify novel leads for the G Protein-Coupled cannabinoid receptors CB1 and CB2. His research has shown to regulate a broad spectrum of physiological conditions from regulating appetite to pain. His study and presentation focused on the Identification of Raloxifene as a Novel CB2 Inverse Agonist.

Pritesh’s Study

Basically, to sum this up in layman’s terms; Pritesh’s study found that Raloxifene (marketed as Evista by Eli Lilly and Company), an FDA approved drug. It is used for the treatment and prevention of osteoporosis in post-menopausal women, is acting on the cannabinoid receptor 2 (CB2). The dirt: Pritesh identified that an FDA approved is acting on a target other than which it is marketed for which could help explain the known therapeutic effects of this drug for treating / preventing post-menopausal osteoporosis.

USB Art Museum

Upon arriving Ed Rosenthal and I traveled down to the UBS Art Museum where the official reception was held for event goers. We spent a considerable amount of time with the lovely Sita von Windheim. After the reception, we connected with a client to discuss Canadian Marihuana for Medical Purposes Regulations Consulting.

The Client needed information pertaining to talent acquisition to good production planning and cultivation best practices. We helped educate him on the first steps in the process. Day two involved a lot of hand shaking and the introduction to Ron Mullins of California NORML, Dr. Dave Allen and Joel from Urban Grower Online.

Day three of theInternational Cannabinoid Research Symposium trip involved an on-site visit to the Urban Grower’s cultivation center. After the grow tour, we enjoyed a nice meal with the group. Day four Ed and I hit the conference hard and afterwards a group of us headed downtown Vancouver to the local watering holes Steamworks Brewery and Lamplighter Pub.

Onsite Engagement Post International Cannabinoid Research Symposium

Day five of the International Cannabinoid Research Symposium trip, six and seven we met with another group in Kelowna, Canada. Ed Rosenthal and I tag teamed an epic 80 light CCH20 Under Current cultivation facility. It was magical watching two of the most respected cultivators explain complex molecular subjects with such simplicity and elegance. The team consulted subjects from water filtration to light optimization.

We made a tremendous amount of contacts and learned many cutting edge cannabinoid treatment advances in the field. I was blessed to be a part of such an amazing event and speaking with some of the most brilliant minds in the cannabinoid research field.

Quantum 9 is the most trusted name in cannabis consulting. Call us today to setup a time to chat with one of our expert cultivation experts. 

Check out our blog.


About Quantum9

Quantum 9, Inc. is a Chicago, IL-based cannabis consulting firm. We specialize in getting high net worth individuals and private equity cannabis business licenses to cultivate, manufacture and dispense marijuana. We have over 50 marijuana consultants that work for the company, and we have practiced in 12 countries. Our areas of expertise include permit acquisition, team building, employee training planning, and process planning. We help clients fully maximize the potential of any cannabis cultivation, processing, and dispensary business.

Leave a Reply

© 2020 Quantum 9, Inc. All Rights Reserved